PARPharmaceuticals

Par Technology CorporationCash Flow Statement

78.58
-7.53%

Par Technology Corporation Cash Flow Statement (Annual)

Metric20252024202420232023
Free Cash Flow14.93 Cr-3.20 Cr14.17 Cr-2.74 Cr5.74 Cr
Repayment Of Debt0.000.000.000.000.00
Issuance Of Debt0.008.73 Cr0.000.000.00
Issuance Of Capital Stock0.0019.45 Cr0.000.000.00
Capital Expenditure-1.23 Cr-0.68 Cr-6.08 Cr-1.04 Cr-7.63 Cr
End Cash Position27.58 Cr12.15 Cr36.65 Cr4.75 Cr22.24 Cr
Other Cash Adjustment Outside Changein Cash1000.001000.00
Beginning Cash Position36.65 Cr4.75 Cr22.24 Cr7.75 Cr16.21 Cr
Changes In Cash-9.08 Cr7.31 Cr14.41 Cr-2.65 Cr6.04 Cr
Financing Cash Flow0.0027.85 Cr0.00-0.16 Cr-24000.00
Interest Paid Cff0.000.00-24000.00
Net Common Stock Issuance0.0018.94 Cr0.00-0.27 Cr0.00
Common Stock Issuance0.0019.45 Cr0.000.000.00
Net Issuance Payments Of Debt0.008.73 Cr0.000.000.00
Net Short Term Debt Issuance0.000.000.00
Short Term Debt Payments0.000.000.00
Net Long Term Debt Issuance0.008.73 Cr0.000.000.00
Long Term Debt Payments0.000.000.000.000.00
Long Term Debt Issuance0.008.73 Cr0.000.000.00
Investing Cash Flow-25.24 Cr-18.01 Cr-5.84 Cr-0.78 Cr-7.34 Cr
Net Other Investing Changes1.05 Cr0.33 Cr0.23 Cr0.10 Cr
Net Investment Purchase And Sale-25.06 Cr3.67 Cr-19000.000.50 Cr0.00
Purchase Of Investment-25.06 Cr-2.84 Cr-19000.00-8.10 Cr0.00
Net PPE Purchase And Sale-1.23 Cr-6.07 Cr-7.43 Cr
Sale Of PPE0.000.01 Cr0.20 Cr
Purchase Of PPE-1.23 Cr-6.08 Cr-7.63 Cr
Operating Cash Flow16.16 Cr-2.52 Cr20.25 Cr-1.71 Cr13.38 Cr
Taxes Refund Paid-4.52 Cr-4.36 Cr-4.26 Cr
Change In Working Capital0.17 Cr0.54 Cr2.00 Cr1.77 Cr-0.46 Cr
Change In Other Current Liabilities-0.84 Cr-0.03 Cr-0.04 Cr-0.04 Cr1.19 Cr
Change In Other Current Assets0.16 Cr-0.34 Cr0.35 Cr-0.28 Cr0.28 Cr
Change In Payable5.54 Cr0.75 Cr-2.74 Cr0.74 Cr-2.57 Cr
Change In Inventory-1.93 Cr0.18 Cr1.20 Cr1.60 Cr-0.67 Cr
Change In Receivables-2.91 Cr-1.05 Cr3.32 Cr-0.08 Cr1.51 Cr
Other Non Cash Items-1.05 Cr0.18 Cr-0.23 Cr-0.70 Cr-0.09 Cr
Deferred Tax-0.01 Cr-1.08 Cr-0.11 Cr0.02 Cr0.03 Cr
Depreciation And Amortization3.65 Cr3.79 Cr3.44 Cr2.70 Cr3.23 Cr
Depreciation3.65 Cr3.44 Cr3.23 Cr
Net Income From Continuing Operations17.92 Cr-8.99 Cr19.52 Cr-8.16 Cr15.08 Cr
Repurchase Of Capital Stock-0.51 Cr-0.27 Cr
Income Tax Paid Supplemental Data0.23 Cr0.32 Cr
Effect Of Exchange Rate Changes0.09 Cr-0.35 Cr
Cash Flow From Continuing Financing Activities27.85 Cr-0.16 Cr
Net Other Financing Charges-0.15 Cr
Proceeds From Stock Option Exercised0.32 Cr0.11 Cr
Common Stock Payments-0.51 Cr-0.27 Cr
Cash From Discontinued Investing Activities9.61 Cr-0.05 Cr
Cash Flow From Continuing Investing Activities-27.62 Cr-0.73 Cr
Sale Of Investment6.51 Cr8.60 Cr0.00
Net Business Purchase And Sale-30.94 Cr-0.19 Cr
Purchase Of Business-30.94 Cr-0.19 Cr
Capital Expenditure Reported-0.68 Cr-1.04 Cr
Cash From Discontinued Operating Activities-0.39 Cr1.49 Cr
Cash Flow From Continuing Operating Activities-2.13 Cr-3.20 Cr
Change In Other Working Capital-0.03 Cr-0.22 Cr
Change In Payables And Accrued Expense1.81 Cr0.79 Cr
Change In Accrued Expense1.06 Cr0.05 Cr
Change In Account Payable0.43 Cr0.44 Cr
Changes In Account Receivables-1.05 Cr-0.08 Cr
Stock Based Compensation2.45 Cr1.43 Cr
Provisionand Write Offof Assets0.24 Cr-0.13 Cr
Asset Impairment Charge0.02 Cr0.00
Amortization Of Securities0.05 Cr-0.19 Cr
Deferred Income Tax-1.08 Cr0.02 Cr
Depreciation Amortization Depletion3.79 Cr2.70 Cr
Operating Gains Losses0.66 Cr0.06 Cr
Gain Loss On Investment Securities-82000.00-0.14 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.